Incidence and recurrence of atrial fibrillation among patients with obstructive hypertrophic cardiomyopathy treated with mavacamten: a single-center experience

Clin Res Cardiol. 2024 Jul 31. doi: 10.1007/s00392-024-02496-1. Online ahead of print.
No abstract available

Publication types

  • Letter